Shiro Onozawa

583 citations
54 papers · 421 indexed · h-index 11
Topics
Hepatocellular Carcinoma Treatment and Prognosis (10 papers)Abdominal vascular conditions and treatments (8 papers)Liver Disease and Transplantation (8 papers)

In The Last Decade

Shiro Onozawa

53 papers receiving 411 citations

Peers

Shiro Onozawa
Comparison fields: 5 of 48
  • Surgery 244
  • Pulmonary and Respiratory Medicine 141
  • Hepatology 119
  • Epidemiology 54
  • Endocrinology, Diabetes and Metabolism 51
Replace Daisuke Yasui with:
Daisuke Yasui Japan
Shuji Nishikawa Japan
Sebastian Schotten Germany
Emanuele Boatta Italy
Nikolaos Ptohis Greece
P. Sandbichler Austria
Gregory Dubel United States
Peter U. Reber Switzerland
Shams Iqbal United States
Arturo Soriano Spain
Shiro Onozawa relative to Daisuke Yasui Japan Daisuke Yasui's profile →
Citations per field
00.5×6.4×
Daisuke Yasui · 1×
Citations per year

Countries citing papers authored by Shiro Onozawa

Since Specialization
Citations

This map shows the geographic impact of Shiro Onozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Onozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Onozawa more than expected).

Fields of papers citing papers by Shiro Onozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Onozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Onozawa. The network helps show where Shiro Onozawa may publish in the future.

Co-authorship network of co-authors of Shiro Onozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Onozawa. A scholar is included among the top collaborators of Shiro Onozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Onozawa. Shiro Onozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 17
3 1
4 0
5 7
6 1
7 1
8 3
9 7
10 1
11 1
12 5
13 22
14 6
15 4
16 5
17 1
18 36
19 5
20 11

About Shiro Onozawa

Shiro Onozawa is a scholar working on Hepatology, Internal Medicine and Surgery, having authored 54 papers that have together received 421 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Abdominal vascular conditions and treatments (8 papers) and Liver Disease and Transplantation (8 papers). The work is most often cited by research in Hepatology (119 citations), Gastroenterology (50 citations) and Internal Medicine (21 citations). Shiro Onozawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Satoru Murata, Shin‐ichiro Kumita, Takahiko Mine, Hiroyuki Tajima, Tatsuo Ueda, Daisuke Yasui, Hidenori Yamaguchi, Kazuhiro Nomura, Yutaka Abe and Hitoshi Sugihara. Their work appears in journals such as Radiology, American Journal of Roentgenology and Journal of Vascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026